Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
584
-
Total 13F shares, excl. options
-
25M
-
Shares change
-
+459K
-
Total reported value, excl. options
-
$10.1B
-
Value change
-
+$221M
-
Put/Call ratio
-
0.67
-
Number of buys
-
262
-
Number of sells
-
-281
-
Price
-
$404.15
Significant Holders of Medpace Holdings, Inc. - Common Stock (MEDP) as of Q1 2024
635 filings reported holding MEDP - Medpace Holdings, Inc. - Common Stock as of Q1 2024.
Medpace Holdings, Inc. - Common Stock (MEDP) has 584 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25M shares
of 30.9M outstanding shares and own 80.85% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2.5M shares), BlackRock Inc. (2.49M shares), WASATCH ADVISORS LP (974K shares), Invesco Ltd. (816K shares), STATE STREET CORP (697K shares), RIVERBRIDGE PARTNERS LLC (606K shares), TD Asset Management Inc (574K shares), GEODE CAPITAL MANAGEMENT, LLC (533K shares), GOLDMAN SACHS GROUP INC (528K shares), and Epoch Investment Partners, Inc. (406K shares).
This table shows the top 584 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.